Results 81–100 of 2292 for speaker:George Freeman

Written Answers — Department of Health: Medical Treatments (12 Jul 2016)

George Freeman: The decision to be treated privately outside the National Health Service is one for individuals and their clinicians to make, in accordance with the relevant professional and regulatory requirements. Guidance on NHS patients who wish to pay for additional private care was issued in 2009 and is available at: www.gov.uk/government/uploads/system/uploads/attachment_data...

Written Answers — Department of Health: Drugs (12 Jul 2016)

George Freeman: The Government expects to publish the review it commissioned on the independently chaired Accelerated Access Review shortly. The Review team are currently considering publication dates.

Written Answers — Department of Health: Respiratory Syncytial Virus: Babies (11 Jul 2016)

George Freeman: I refer the hon. Member to the Answer I gave to the hon. Member for Ealing, Southall (Mr Virendra Sharma) on 28 June 2016 to Question 40748.

Written Answers — Department of Health: Hospitals: Waiting Lists (11 Jul 2016)

George Freeman: The Government has fully funded the National Health Service’s Five Year Forward View, so that the NHS will receive £10 billion more in real terms by 2020-21 than in 2014-15. This additional funding, alongside measures to improve efficiency and reduce waste will enable delivery of the Government’s mandate to NHS England. The Government’s mandate to NHS England for 2016-17 sets out...

Written Answers — Department for Business, Innovation and Skills: Medical Treatments (8 Jul 2016)

George Freeman: The Accelerated Access Review team is a joint unit between the Department of Health and the Department for Business, Innovation and Skills. The Accelerated Access Review is intended to reform the landscape for the assessment, adoption and reimbursement of innovative drugs, devices and other treatments across all therapeutic areas.

Written Answers — Department of Health: Antibiotics (8 Jul 2016)

George Freeman: Discussions between Departmental officials and the Association of the British Pharmaceutical Industry concerning pricing and reimbursement models for antibiotics are ongoing and the topic will in due course feature in the established cross-government dialogue on antimicrobial resistance. Additionally, I am planning United Kingdom-wide collaboration as part of the first meeting of Ministers...

Backbench Business: Blood Cancers — [Mr Charles Walker in the Chair] (7 Jul 2016)

George Freeman: It is a great pleasure to serve under your chairmanship, Mr Walker. I thank and congratulate the hon. Member for Strangford (Jim Shannon) and my hon. Friend the Member for Crawley (Henry Smith) on setting up the all-party parliamentary group and initiating this debate. It is another example of Westminster Hall providing an important forum as an adjunct to the main Chamber for hon. Members...

Backbench Business: Blood Cancers — [Mr Charles Walker in the Chair] (7 Jul 2016)

George Freeman: The hon. Lady makes an excellent point. I thank her for it and endorse her sentiments. In several research areas important initiatives have been taken by black and minority ethnic and other communities with particular genetic predispositions. It is important that we support those initiatives, which I very much welcome. The Genomics England programme operates on an explicit volunteer consent...

Backbench Business: Blood Cancers — [Mr Charles Walker in the Chair] (7 Jul 2016)

George Freeman: I completely agree with my hon. Friend. As she has made clear, and as I repeated earlier, it is tricky because the symptoms are not always straightforward or simple. It is often not a lump or something that is easily detectable, and the symptoms can easily be confused with those of other conditions that many of us might all too easily brush off and dismiss as the result of tiredness, fatigue...

Backbench Business: Blood Cancers — [Mr Charles Walker in the Chair] (7 Jul 2016)

George Freeman: I am grateful to the hon. Gentleman for reading my mind—not for the first time—because the next paragraph in my speech is about the cancer drugs fund and the accelerated access review. His intervention gives me a moment to highlight some of the important points that colleagues have made. The hon. Gentleman, who is something of a biomedical stalker of mine on these occasions, as he...

Backbench Business: Blood Cancers — [Mr Charles Walker in the Chair] (7 Jul 2016)

George Freeman: That was achieved in an extraordinary manoeuvre, which was so seamless I did not even notice it happening over my left shoulder. This summer, officials in the Department of Health will work with the accelerated access review team and NHS England to try to strike a blow for an integrated healthcare innovation economy that makes best use of our budgets. Let me put it on the record that these...

Written Answers — Department of Health: Health Services (7 Jul 2016)

George Freeman: The measurement of scientific and diagnostic services was more complex than originally envisaged which meant that the 70% target for these services to be part of an accreditation programme was difficult to quantify. NHS England continues to lead a programme of work to increase the number of scientific and diagnostic services that are part of accreditation programmes and demonstrate robust...

Written Answers — Department of Health: Clinical Commissioning Groups: Pay (7 Jul 2016)

George Freeman: Clinical commissioning groups are autonomous bodies which are responsible for managing spend as they deem appropriate. However, NHS England has published the guidance Clinical Commissioning Groups: Remuneration guidance for Chief Officers (where the senior manager also undertakes the accountable officer role) and Chief Finance Officers which can be found at this address: ...

Written Answers — Department of Health: Clinical Commissioning Groups: Pay (7 Jul 2016)

George Freeman: Information on the remuneration of chairs is held by individual clinical commissioning groups and not collected centrally.

Written Answers — Department of Health: Brain: Tumours (6 Jul 2016)

George Freeman: The Department of Health Task and Finish Working Group on Brain Tumour Research is bringing together clinicians, charities and officials to discuss how, working together with research funding partners, we can address the need to increase the level and impact of research into this devastating disease. The Working Group will be chaired by Professor Chris Whitty, the Department’s Chief...

Written Answers — Department of Health: West Cumberland Hospital (6 Jul 2016)

George Freeman: This is a matter for the North Cumbria University Hospitals NHS Trust. The Trust provided an update on progress in relation to delivery of Phase 2 of the re-development of West Cumberland Hospital in a press release issued in June 2015: http://www.ncuh.nhs.uk/news/2015/june/trust-planning-next-ph ase-of-west-cumberland-hospital-redevelopment.aspx NHS Improvement advises that the Trust is...

Written Answers — Department of Health: NHS Professionals (6 Jul 2016)

George Freeman: Currently NHS Professionals Ltd works with around a third of National Health Service trusts, saving over £40 million a year by providing bank staff cheaper than agencies. The Department's sole objective is to expand this good work into more trusts, thus boosting efficiency and improving patient care. The Department has been exploring a range of potential options, to help NHS Professionals...

Written Answers — Department of Health: Obesity: Surgery (6 Jul 2016)

George Freeman: It is for clinicians to decide when bariatric surgery is appropriate based on the need of the patient and in line with appropriate guidance, including that issued by the National Institute for Health and Care Excellence.

Written Ministerial Statements — Department of Health: The Care Quality Commission and National Data Guardian for Health and Care’s Independent Reviews into Data Security, Consent and Opt-Outs (6 Jul 2016)

George Freeman: Today, two independent reviews have been published which make recommendations about data security in the health and care system in England and a new consent/opt-out model for data sharing. In September 2015, I commissioned the Care Quality Commission (CQC) to undertake a review of data security in the NHS and, in parallel, commissioned Dame Fiona Caldicott, the National Data Guardian for...

Oral Answers to Questions — Health: Cost of Interpreters (5 Jul 2016)

George Freeman: Until now, data on NHS foreign language translation and interpretation have not been gathered centrally, but I am delighted to say that, as a result of the representations of my hon. Friend and other colleagues, we have changed that, and NHS England is now conducting a major piece of work looking at both commissioning and provider organisations’ expenditure as part of a procurement review....


<< < 1 2 3 4 5 6 7 8 9 10 > >>

Create an alert

Did you find what you were looking for?

Advanced search

Find this exact word or phrase

You can also do this from the main search box by putting exact words in quotes: like "cycling" or "hutton report"

By default, we show words related to your search term, like “cycle” and “cycles” in a search for cycling. Putting the word in quotes, like "cycling", will stop this.

Excluding these words

You can also do this from the main search box by putting a minus sign before words you don’t want: like hunting -fox

We also support a bunch of boolean search modifiers, like AND and NEAR, for precise searching.

Date range

to

You can give a start date, an end date, or both to restrict results to a particular date range. A missing end date implies the current date, and a missing start date implies the oldest date we have in the system. Dates can be entered in any format you wish, e.g. 3rd March 2007 or 17/10/1989

Person

Enter a name here to restrict results to contributions only by that person.

Section

Restrict results to a particular parliament or assembly that we cover (e.g. the Scottish Parliament), or a particular type of data within an institution, such as Commons Written Answers.

Column

If you know the actual Hansard column number of the information you are interested in (perhaps you’re looking up a paper reference), you can restrict results to that; you can also use column:123 in the main search box.